Metabolite pathway mapping in Euglena: A strategy for predictable product optimization
Noblegen Inc. is an advanced bioproducts manufacturer dedicated to developing cost-effective, naturally-derived biomaterials and biochemicals for a wide range of consumer and industry sectors. We employ a unique organism, algae, to continue to do what it does naturally – decontaminate wastewater sustainably and affordably while also generating valuable biomass for use in biomaterials and biochemicals production. In this research, we propose to map out the pathways that are active in algae. Based on these pathways we will determine how various culture conditions and strategies can optimize algal growth and oil production with a desired fatty acid composition.
View Full Project DescriptionNeil Emery
Noblegen Inc
Life Sciences
Professional, scientific and technical services
Trent University
Accelerate